Actinium Pharmaceuticals: The Trickle Down Continues, And I Maintain A Buy (NYSE:ATNM)
da-kuk Topline Summary and Changes to the Thesis Actinium Pharmaceuticals, Inc. (NYSE:ATNM) continues to push forward with their radiolabelled CD45 ...
da-kuk Topline Summary and Changes to the Thesis Actinium Pharmaceuticals, Inc. (NYSE:ATNM) continues to push forward with their radiolabelled CD45 ...
lindsay_imagery/E+ through Getty Photos I coated Actinium (ATNM) in July after which once more in December. In July, I mentioned ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.